Search research articles
Contact Us
Filters
Showing results (251-260 of 304) with videos related to
Page
of 31
Sort By:
Urologic Oncology
|
November 10, 2019
Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer
Ahmad S Halwani, Kelli M Rasmussen, Vikas Patil, et al.
Urologic Oncology
|
October 8, 2024
Comparison of outcomes between single-port and multiport retroperitoneal robotic partial nephrectomy
Kennedy E Okhawere, Alp Tuna Beksac, Ethan Ferguson, et al.
JAMA Internal Medicine
|
February 18, 2020
Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia
Barbara Ellen Jones, Jian Ying, Vanessa Stevens, et al.
Seminars in Arthritis and Rheumatism
|
April 14, 2023
Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reports
Brent A Luedders, Brendan J Cope, Daniel Hershberger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 13, 2025
Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease
Vanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 24, 2025
Reply
Vanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
The Lancet. Rheumatology
|
January 10, 2025
Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study
Bryant R England, Joshua F Baker, Michael D George, et al.
International Immunopharmacology
|
May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort
Bryant R England, Megan Campany, Harlan Sayles, et al.
Seminars in Arthritis and Rheumatism
|
April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user study
Halie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 9, 2026
Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid Arthritis
Tate M Johnson, Halie Frideres, Punyasha Roul, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 304) with videos related to
Sort By:
Page
of 31
Urologic Oncology
|
November 10, 2019
Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer
Ahmad S Halwani, Kelli M Rasmussen, Vikas Patil, et al.
Urologic Oncology
|
October 8, 2024
Comparison of outcomes between single-port and multiport retroperitoneal robotic partial nephrectomy
Kennedy E Okhawere, Alp Tuna Beksac, Ethan Ferguson, et al.
JAMA Internal Medicine
|
February 18, 2020
Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia
Barbara Ellen Jones, Jian Ying, Vanessa Stevens, et al.
Seminars in Arthritis and Rheumatism
|
April 14, 2023
Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reports
Brent A Luedders, Brendan J Cope, Daniel Hershberger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 13, 2025
Associations of Fire Smoke and Other Pollutants With Incident Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease
Vanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 24, 2025
Reply
Vanessa L Kronzer, Yangyuna Yang, Punyasha Roul, et al.
The Lancet. Rheumatology
|
January 10, 2025
Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study
Bryant R England, Joshua F Baker, Michael D George, et al.
International Immunopharmacology
|
May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort
Bryant R England, Megan Campany, Harlan Sayles, et al.
Seminars in Arthritis and Rheumatism
|
April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user study
Halie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 9, 2026
Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid Arthritis
Tate M Johnson, Halie Frideres, Punyasha Roul, et al.
Page
of 31